← Oncology Approval Tracker

FDA DECISION ·

Koselugo

selumetinib · AstraZeneca

FDA approvalNew therapyNF1-associated plexiform neurofibromas
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Children ages two years and older with neurofibromatosis type 1 and symptomatic, inoperable plexiform neurofibromas, a type of benign nerve sheath tumor.

LAMPGEN ANALYSIS

Why it matters

Provided an approved drug for children with symptomatic tumors that could not be removed surgically.

What research teams should watch

Use consistent imaging and symptom assessments and arrange cardiac and eye monitoring.

PRIMARY RECORDS

Sources